UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination

Alimentary pharmacology & therapeutics, 2020-09, Vol.52 (5), p.866-876

2020

Volltextzugriff (PDF)

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

The lancet. Gastroenterology & hepatology, 2019-05, Vol.4 (5), p.389-398

2019

Volltextzugriff (PDF)

Editorial: Retreatment of direct‐acting antiviral failures with the current first‐line regimens for patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2024-07, Vol.60 (2), p.276-277

Ogawa, Eiichi

2024

Volltextzugriff (PDF)

Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight—Authors' reply

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (7), p.909-910

Ogawa, Eiichi

2024

Volltextzugriff (PDF)

Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy—Author's reply

Alimentary pharmacology & therapeutics, 2023-10, Vol.58 (8), p.845-846

Ogawa, Eiichi

2023

Volltextzugriff (PDF)

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

Hepatology international, 2021-04, Vol.15 (2), p.366-379

2021

Volltextzugriff (PDF)

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

The American journal of gastroenterology, 2020-02, Vol.115 (2), p.271-280

2020

Volltextzugriff (PDF)

Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B ‐ author's reply

Alimentary pharmacology & therapeutics, 2022-09, Vol.56 (6), p.1092-1093

Ogawa, Eiichi

2022

Volltextzugriff (PDF)

Editorial: the role for PIVKA‐II measurement after HCV elimination by direct‐acting anti‐virals in terms of prediction of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.122-123

Ogawa, Eiichi

2022

Volltextzugriff (PDF)

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Hepatology research, 2019-06, Vol.49 (6), p.617-626

2019

Volltextzugriff (PDF)

Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir

The American journal of gastroenterology, 2021-06, Vol.116 (6), p.1264-1273

2021

Volltextzugriff (PDF)

Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-01, Vol.26 (1), p.28-32

2020

Volltextzugriff (PDF)

Editorial: FAST score‐ a new predictive marker for HCC after SVR—author's reply

Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (7), p.1224-1224

Ogawa, Eiichi

2020

Volltextzugriff (PDF)

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Journal of gastroenterology, 2017-07, Vol.52 (7), p.845-854

2017

Volltextzugriff (PDF)

Secondary Syphilis with Pulmonary Involvement

Internal Medicine, 2018/01/01, Vol.57(1), pp.121-126

2018

Volltextzugriff (PDF)

Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B

World journal of gastroenterology : WJG, 2015-02, Vol.21 (7), p.2116-2123

2015

Volltextzugriff (PDF)

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Hepatology research, 2020-02, Vol.50 (2), p.174-181

2020

Volltextzugriff (PDF)

Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm

Internal Medicine, 2019/09/15, Vol.58(18), pp.2737-2741

2019

Volltextzugriff (PDF)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy

Drug design, development and therapy, 2017-01, Vol.11, p.3197-3204

2017

Volltextzugriff (PDF)

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Journal of hepatology, 2013-10, Vol.59 (4), p.667-674

2013

Volltextzugriff (PDF)

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog

Hepatology research, 2011-12, Vol.41 (12), p.1178-1188

2011

Volltextzugriff (PDF)

A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-08, Vol.28 (8), p.1208-1211

2022

Volltextzugriff (PDF)

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

Hepatology international, 2020-12, Vol.14 (6), p.1023-1033

2020

Volltextzugriff (PDF)

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Hepatology research, 2017-03, Vol.47 (3), p.E120-E131

2017

Volltextzugriff (PDF)

Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: Results from the Kyushu and Okinawa Population Study (KOPS)

Atherosclerosis, 2015-02, Vol.238 (2), p.207-212

2015

Volltextzugriff (PDF)

1 – 25 von 1.075

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(698)
Mit Volltextzugriff
(861)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

Editorial: Retreatment of direct‐acting antiviral failures with the current first‐line regimens for patients with chronic hepatitis C

Letter: Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B can increase body weight—Authors' reply

Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus‐related hepatocellular carcinoma after curative hepatectomy—Author's reply

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040

Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B

Editorial: switching to tenofovir alafenamide monotherapy is effective and safe for other nucleos(t)ide analogues‐treated patients with chronic hepatitis B ‐ author's reply

Editorial: the role for PIVKA‐II measurement after HCV elimination by direct‐acting anti‐virals in terms of prediction of hepatocellular carcinoma

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir

Prevalence and characteristics of occult hepatitis B virus infection in Japanese human immunodeficiency virus-infected patients

Editorial: FAST score‐ a new predictive marker for HCC after SVR—author's reply

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Secondary Syphilis with Pulmonary Involvement

Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog

A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy

HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Subclinical carotid atherosclerosis and triglycerides predict the incidence of chronic kidney disease in the Japanese general population: Results from the Kyushu and Okinawa Population Study (KOPS)

Suchergebnisse filtern